Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 5, 2024
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
Joseph Stringer Reiterated (CARA) at Strong Buy and Held Target at $5 on, Mar 5th, 2024
Joseph Stringer of Needham, Reiterated "Cara Therapeutics, Inc." (CARA) at Strong Buy and Held Target at $5 on, Mar 5th, 2024.
Joseph has made no other calls on CARA in the last 4 months.
There are 2 other peers that have a rating on CARA. Out of the 2 peers that are also analyzing CARA, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Amsellem of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $1 on, Tuesday, November 14th, 2023
This is the rating of the analyst that currently disagrees with Joseph
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $2.5 on, Tuesday, December 19th, 2023
